Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

AQST - Aquestive Therapeutics, Inc.... | Finranks

Home

/

AQST

A

Aquestive Therapeutics, Inc. (AQST)

NGM – Real Time Price. Currency in USD

4.32

-0.09 (-2.04%)

Market open: Aug 12, 2026, 2:08 PM EDT

4.38

-0.03 (-0.68%)

Previous after-hours: Aug 11, 2026, 7:57 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

45M

58M

51M

48M

Cost of goods sold

-17M

-18M

-21M

-20M

Gross Profit

27M

40M

30M

28M

Operating expenses (excl. COGS)

-97M

-70M

-45M

-70M

Operating Income

-70M

-31M

-15M

-42M

Non-operating income, total

-13M

-13M

7M

-12M

Pretax income

-84M

-44M

-8M

-54M

Equity in earnings

0

0

0

0

Taxes

0

14K

-245K

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-84M

-44M

-8M

-54M

Discontinued operations

0

0

0

0

Net income

-84M

-44M

-8M

-54M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

162M+59.9%

101M+76.6%

57M+0.6%

57M

Total current assets

149M

88M

41M

40M

Total non-current assets

13M

13M

16M

17M

Total liabilities

196M+21.2%

162M-1.4%

164M-6.7%

176M

Total current liabilities

48M

19M

18M

40M

Total non-current liabilities

148M

143M

146M

136M

Total equity

-34M

-60M

-106M

-119M

Total liabilities & shareholders' equities

162M

101M

57M

57M

Total debt

131M+7.8%

122M+23.4%

99M-19.5%

123M

Name

2025

2024

2023

2022

Cash from operating activities

-52M

-36M

-6M

-10M

Cash from investing activities

-562K

-159K

-995K

-3M

Cash from financing activities

103M

84M

4M

12M

Free cash flow

-53M-47.5%

-36M-387.0%

-7M+31.8%

-11M